Opaleye Management Inc. Ideaya Biosciences, Inc. Transaction History

Opaleye Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $2.18 Million - $3.08 Million	-103,500 Reduced 24.94%	311,500 $8.4 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $959,760 - $1.84 Million	72,000 Added 20.99%	415,000 $9.75 Million
Q1 2023 May 12, 2023	BUY	$13.49 - $18.72 $2.75 Million - $3.82 Million	204,200 Added 147.12%	343,000 $4.71 Million
Q4 2022 Feb 10, 2023	BUY	$14.47 - $18.17 $1.99 Million - $2.49 Million	137,300 Added 9153.33%	138,800 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $13,860 - $23,685	1,500 New	1,500 $22,000

216

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.31B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.